| 18 April 2019 | A specific CNOT1 mutation results in a novel syndrome of pancreatic agenesis and holoprosencephaly through impaired pancreatic and neurological development | De Franco, E; Watson, RA; Weninger, WJ; et al. |
| 5 October 2014 | Defining the role of common variation in the genomic and biological architecture of adult human height. | Wood, AR; Esko, T; Yang, J; et al. |
| 1 May 2019 | Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors | Warrington, NM; Beaumont, RN; Horikoshi, M; et al. |
| 20 October 2019 | A genome-wide association study implicates multiple mechanisms influencing raised urinary albumin-creatinine ratio. | Casanova, F; Tyrrell, J; Beaumont, RN; et al. |
| 16 January 2013 | Biallelic PDX1 (insulin promoter factor 1) mutations causing neonatal diabetes without exocrine pancreatic insufficiency | De Franco, E; Shaw-Smith, C; Flanagan, SE; et al. |
| 6 December 2012 | GATA6 mutations cause a broad phenotypic spectrum of diabetes from pancreatic agenesis to adult-onset diabetes without exocrine insufficiency | De Franco, E; Shaw-Smith, C; Flanagan, SE; et al. |
| 18 December 2019 | Patterns of postmeal insulin secretion in individuals with sulfonylurea-treated KCNJ11 neonatal diabetes show predominance of non-K ATP -channel pathways | Bowman, P; McDonald, TJ; Knight, BA; et al. |
| 20 August 2019 | Clusters provide a better holistic view of type 2 diabetes than simple clinical features – Authors' reply | Dennis, JM; Shields, BM; Henley, WE; et al. |
| 5 July 2019 | Type 1 diabetes genetic risk score discriminates between monogenic and Type 1 diabetes in children diagnosed at the age of < 5 years in the Iranian population | Yaghootkar, H; Abbasi, F; Ghaemi, N; et al. |
| 27 December 2019 | De novo mutations in EIF2B1 affecting eIF2 signaling cause neonatal/early onset diabetes and transient hepatic dysfunction | De Franco, E; Caswell, R; Johnson, M; et al. |
